Ozanimod

yup. Both of the “Jason’s” were canned. Can’t make this stuff up. Both are horrific leaders. Amateur hour folks. Amateur hour.

 

Great- I just joined the team and don't feel too inspired by reading this. Who hired these guys if they were canned from a competitor?

 

inspired. You are in for a real rude awaking. JR is as phony as they come. He doesn’t even look at you when you speak to him. Must be the stroke he had in his gross face that makes his mind wander. Can’t stand that guy!!!!!!!!

 

Sherry L must be clueless. Saw her phony video on LinkedIn too. She's in over her head. But she is surrounded by two ass clowns who will make her look and feel great.

 

Romano here, I’ll kick the shit out of you soy boy!

 

Any offers yet?

 

Nah- we ended up pulling the plug on this POS molecule. It had about 1% market share potential and just not worth moving forward with.

 

Why did JR have such a hard time filling his DBM spots? What can we take from that?

 

Does BMS even care about this drug? What experience do they have in MS?

 

Is it true that panel interviews are the next couple of weeks?

 

When are they going to start hiring the reps for this drug???? Lots of chatter and very little movement..... Hmmmmm....

 

BMS acquisition finalized November 18. After that.

 

They better beat Novartis to the punch, heard they'll be hiring soon for their B cell therapy.....

 

talk about a Catch-22...BMY or NVS? Damn, either option sucks. You will be a big Pharma robot with two of the three worst ever.

 

Not true. I’ve already had a phone screen with recruiter and f2f is coming up in a few weeks. They are moving forward with interviews now. No word on compensation packages yet tho.

 

All DBMs are in Dallas this week for their first meeting. Phone interviews will continue and many face to face interviews will occur prior to Thanksgiving. No word on compensation details. I’m interested in that information for sure if anyone has been told ranges.

 

I was told that even though they want to move ahead, they were recently told by BMY that they have to interview BMY candidates who were let go before they can extend me an offer. Sounds a bit big Pharma like and that is worrisome.

 

Not many from BMS are being let go. Only ones affected will be a few oncology reps in select areas. Less than 30 if that. Celgene has many hematology roles that they will fill so many have already slid into the hem jobs. Many more will be open. Hire date is expected at end of January for this role. Offers will go out mid to end of December per hiring DBM.

 

Thanks for informative post that is helpful and not from a disgruntled troll. I have phone screen at end of this week I have questions but going into it with both eyes wide open.

 

Yes thank you as well. Sometimes things are so negative on CP, and many times warranted. I've got f2f interview coming as well, but right after thanksgiving. Sure wish I could get a read on the likelihood of approval. It sounds good so far but who knows for sure. I'd be leaving my current job and if the drug doesn't make it-I'd be out of a job. This industry. The BMS buy has me a little concerned.